Brief: Axonics Receives Health Canada Approval For Fourth-Generation Rechargeable Sacral Neuromodulation System
13/12/2022 11:07
Dec 13 (Reuters) - Axonics Inc AXNX.O :
* AXONICS RECEIVES HEALTH CANADA APPROVAL FOR
FOURTH-GENERATION
RECHARGEABLE SACRAL NEUROMODULATION SYSTEM
* AXONICS INC - AXONICS HAS COMMENCED SALES OF R20 SACRAL
NEUROMODULATION SYSTEM TO CUSTOMERS IN CANADA
* AXONICS INC - COMPANY ANTICIPATES FDA APPROVAL AND PLANS
TO
COMMERCIALLY LAUNCH R20 SACRAL NEUROMODULATION SYSTEM IN UNITED
STATES IN Q1 OF 2023
Source text for Eikon: ID:nBw4sbrBa
Further company coverage: AXNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axonics
See all newsBrief: Boston Scientific Closes Acquisition Of Axonics, Inc.
Axonics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Axonics Q3 Basic EPS USD 0
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview